FDA recall D-0689-2021
Teligent Pharma, Inc. · Class III · drug
Product
Erythromycin Topical Solution USP, 2% 60 mL, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310, NDC 52565-027-59
Reason for recall
Failed Impurities/Degradation Specifications
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2021-06-22
- Report date
- 2021-07-28
- Termination date
- 2024-07-03
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Buena, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0689-2021